Category: HealthSubscribe via RSS Feed

AstraZeneca pays 660pct premium for gene therapy firm LogicBio

04-Oct-2022 Intellasia | Reuters | 5:02 AM

Shares of LogicBio Therapeutics (LOGC.O) skyrocketed on Monday after Britain’s AstraZeneca’s (AZN.L) said it would buy the US-based gene therapy developer at a [...] » More

Nobel medicine prize goes to explorer of ancient DNA

04-Oct-2022 Intellasia | Reuters | 5:02 AM

Swedish geneticist Svante Paabo won the 2022 Nobel Prize in Physiology or Medicine on Monday for discoveries that underpin our understanding of how modern day humans evolved [...] » More

Shionogi says COVID pill trial shows reduction in symptoms

29-Sep-2022 Intellasia | Reuters | 5:02 AM

Japan’s Shionogi & Co Ltd (4507.T) said on Wednesday its oral treatment for COVID-19 demonstrated a significant reduction in symptoms compared with a placebo in a [...] » More

CRUCIAL PROGRESS FOR WOMEN IN STEM BUT MUCH MORE WORK TO DO

22-Sep-2022 Intellasia | Press Release | 5:02 AM

The number of women enrolled in STEM degrees jumped by 24 percent between 2015 and 2020, bringing 17,000 more women into STEM study and lifting women’s share of STEM [...] » More

End of Covid pandemic in sight: WHO

16-Sep-2022 Intellasia | AFP | 5:02 AM

The number of newly reported Covid-19 cases has dropped dramatically, the World Health Organization said Wednesday, urging the world to seize the opportunity to end the [...] » More

Second US monkeypox death as virus linked to brain inflammation

15-Sep-2022 Intellasia | AFP | 5:02 AM

A second US death was linked to monkeypox on Tuesday as health authorities published a study describing how two previously healthy young men experienced inflammation of the [...] » More

India approves ‘world’s first’ intranasal COVID-19 vaccine

09-Sep-2022 Intellasia | Kyodo | 5:02 AM

India’s drug regulator has approved what a local vaccine innovator calls the “world’s first” intranasal COVID-19 vaccine, restricted for use in [...] » More

Top scientists join forces to study leading theory behind long Covid

09-Sep-2022 Intellasia | Reuters | 5:02 AM

Top scientists from leading academic centres are banding together to answer a key question about the root cause of long Covid whether fragments of the coronavirus persist in [...] » More

Monkeypox outbreak can be eliminated in Europe, WHO says

31-Aug-2022 Intellasia | Reuters | 5:02 AM

It is possible to eliminate the monkeypox outbreak in Europe, World Health Organization officials said on Tuesday, highlighting evidence that case counts are slowing in a [...] » More

Moderna sues Pfiser/BioNTech for patent infringement over COVID vaccine

27-Aug-2022 Intellasia | Reuters | 5:02 AM

Moderna is suing Pfiser and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they [...] » More

Pfiser’s RSV vaccine found effective, safe among older adults in study

26-Aug-2022 Intellasia | Reuters | 5:02 AM

Pfiser Inc (PFE.N) said on Thursday its vaccine for Respiratory Syncytial Virus (RSV) was effective among older adults in a late-stage study and it plans to file for approval [...] » More

EU regulator to discuss Moderna, Pfiser Omicron shots applications on September 1

25-Aug-2022 Intellasia | Reuters | 5:02 AM

The European Medicines Agency (EMA) will hold an extraordinary meeting on September 1 to discuss applications from Moderna (MRNA.O) and Pfiser (PFE.N)for vaccine boosters [...] » More

Moderna seeks FDA nod for booster shot aimed at Omicron BA.4, BA.5

25-Aug-2022 Intellasia | Reuters | 5:02 AM

Moderna Inc (MRNA.O) on Tuesday sought US authorisation for its COVID-19 booster shot tailored against the BA.4 and BA.5 subvariants of Omicron and said if cleared it would [...] » More

EU regulator to discuss Moderna, Pfiser Omicron shots applications on September 1

24-Aug-2022 Intellasia | Reuters | 9:21 AM

The European Medicines Agency (EMA) will hold an extraordinary meeting on September 1 to discuss applications from Moderna (MRNA.O) and Pfiser (PFE.N)for vaccine boosters [...] » More

Moderna seeks FDA nod for booster shot aimed at Omicron BA.4, BA.5

24-Aug-2022 Intellasia | Reuters | 9:20 AM

Moderna Inc (MRNA.O) on Tuesday sought US authorisation for its COVID-19 booster shot tailored against the BA.4 and BA.5 subvariants of Omicron and said if cleared it would [...] » More